Enliven Therapeutics, Inc. (ELVN): 144 filed Sep 4, 2026

Form type

144

Filing date

Sep 4, 2026

Accession number

0001959173-26-006749

Filer

Enliven Therapeutics, Inc. (CIK 1672619)